Article
 

A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish

Público Deposited

Conteúdo disponível para baixar

Baixar PDF
https://ir.library.oregonstate.edu/concern/articles/ng451k01p

Descriptions

Attribute NameValues
Creator
Abstract
  • Human liver cancer is one of the deadliest cancers worldwide, with hepatocellular carcinoma (HCC) being the most common type. Aberrant Ras signaling has been implicated in the development and progression of human HCC, but a complete understanding of the molecular mechanisms of this protein in hepatocarcinogenesis remains elusive. In this study, a stable in vivo liver cancer model using transgenic zebrafish was generated to elucidate Ras-driven tumorigenesis in HCC. Using the liver-specific fabp10 (fatty acid binding protein 10) promoter, we overexpressed oncogenic kras[superscript V12] specifically in the transgenic zebrafish liver. Only a high level of kras[superscript V12] expression initiated liver tumorigenesis, which progressed from hyperplasia to benign and malignant tumors with activation of the Ras-Raf-MEK-ERK and Wnt–β-catenin pathways. Histological diagnosis of zebrafish tumors identified HCC as the main lesion. The tumors were invasive and transplantable, indicating malignancy of these HCC cells. Oncogenic kras[superscript V12] was also found to trigger p53-dependent senescence as a tumor suppressive barrier in the pre-neoplastic stage. Microarray analysis of zebrafish liver hyperplasia and HCC uncovered the deregulation of several stage-specific and common biological processes and signaling pathways responsible for kras[superscript V12]-driven liver tumorigenesis that recapitulated the molecular hallmarks of human liver cancer. Cross-species comparisons of cancer transcriptomes further defined a HCC-specific gene signature as well as a liver cancer progression gene signature that are evolutionarily conserved between human and zebrafish. Collectively, our study presents a comprehensive portrait of molecular mechanisms during progressive Ras-induced HCC. These observations indicate the validity of our transgenic zebrafish to model human liver cancer, and this model might act as a useful platform for drug screening and identifying new therapeutic targets.
  • This is the publisher’s final PDF plus Supplementary Material. The published article is copyrighted by The Company of Biologists Ltd. and can be found at: http://dmm.biologists.org/
Resource Type
DOI
Date Available
Date Issued
Citation
  • Nguyen, A.T., Emelyanov, A., Koh, C.H., Spitsbergen, J.M., Lam, S.H., Mathavan, S., Parinov, S., and Gong, Z. (2011) A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish. Disease Models & Mechanisms. 4(6):801-13
Journal Title
Journal Volume
  • 4
Journal Issue/Number
  • 6
Academic Affiliation
Declaração de direitos
Funding Statement (additional comments about funding)
  • This work was supported by the Biomedical Research Council of Singapore.
Publisher
Peer Reviewed
Language
Replaces

Relações

Parents:

This work has no parents.

Itens

Miniatura Título Data de carga Acesso Ações
file details SpitsbergenJanMicrobiologyHighLevelLiver.pdf 2017-07-20 Público Baixar